UnitedHealth Group Inc (NYSE:UNH) – Oppenheimer increased their Q2 2018 EPS estimates for UnitedHealth Group in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now expects that the healthcare conglomerate will post earnings of $2.98 per share for the quarter, up from their previous forecast of $2.67. Oppenheimer has a “Outperform” rating and a $240.00 price objective on the stock.
Several other analysts also recently commented on UNH. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research note on Thursday, September 21st. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $210.00 price target on shares of UnitedHealth Group in a research report on Tuesday, October 10th. Jefferies Group raised their target price on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Friday, October 13th. Finally, BMO Capital Markets started coverage on UnitedHealth Group in a research report on Monday, October 16th. They issued an “outperform” rating and a $250.00 target price for the company. Three analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $241.30.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.79% and a net margin of 5.25%. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same quarter in the previous year, the company posted $2.11 EPS. The business’s revenue was up 9.5% on a year-over-year basis.
Large investors have recently bought and sold shares of the business. BlackRock Inc. boosted its stake in UnitedHealth Group by 1.2% during the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. FMR LLC increased its holdings in UnitedHealth Group by 2.1% during the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock valued at $10,402,371,000 after acquiring an additional 1,168,324 shares in the last quarter. Alliancebernstein L.P. increased its holdings in UnitedHealth Group by 2.3% during the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after acquiring an additional 174,290 shares in the last quarter. Finally, TIAA CREF Investment Management LLC grew its holdings in shares of UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after buying an additional 223,524 shares in the last quarter. Institutional investors own 86.09% of the company’s stock.
In other news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,655 shares of company stock valued at $7,469,083. 0.89% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.